QIAGEN NV to acquire Cellesis Limited
08 April, 2011
QIAGEN NV has reached an agreement to acquire Cellesis Limited, which will provide them with access to QuantiFERON technology.
Beckman Coulter highlights workflow solutions at LabAutomation 2011
05 April, 2011 | Supplied by: Beckman Coulter Australia
Beckman Coulter featured seamless, automated workflow solutions and improvements in throughput and cellular analysis at the LabAutomation 2011 conference in Palm Springs, California. In addition to workshops and scientific posters, the exhibit showcased applications and systems dedicated to next generation sequencing (NGS) sample preparation, stem cell research, assay screening miniaturization and more.
Alliance provides one-stop biosafety testing service
05 April, 2011 | Supplied by: Beckman Coulter Australia
Beckman Coulter Genomics and Vitrology Ltd have announced a strategic partnership to offer customers a wide range of biosafety testing services. The alliance provides the biopharmaceutical industry with two inclusive sources for the full complement of molecular, in vitro and in vivo genomic services necessary for the identification, stabilisation and purification of biological products.
Deloitte sponsors competition to better predict chess outcomes
31 March, 2011
Kaggle announces that Deloitte is sponsoring a competition aimed at using data analytics to find the most accurate rating system to predict chess outcomes, which will in turn help solve business problems.
RAC and SEAC adopt their first opinions on restriction proposals
17 March, 2011
The RAC has adopted two proposals, to restrict DMFu in articles and to restrict lead in jewellery, which are supported by SEAC.
Thermo Fisher Scientific opens Center of Excellence for POPs
16 March, 2011
Thermo Fisher Scientific has announced the opening of the Center of Excellence for POPs, which will partner with laboratories to improve the quality and efficiency of global POPs monitoring.
Australian Infectious Diseases Research Center opened
15 March, 2011
The Australian Infectious Diseases Research Centre has been opened in Brisbane as a response to the global need to combat disease outbreaks and to develop new vaccines.
NHMRC provides high-level research programs
09 March, 2011
Nine medical research programs provided through the NHMRC have been announced, and they will help boost Australia's reputation as an international leader in research.
Antibacterial sales to decline
08 March, 2011
Despite a number of new hospital brands to be launched targeting serious infections caused by multidrug-resistant bacteria, there will be a market decline caused by genericisation, safety concerns and resistance of leading antibacterial brands.
Computational science expert awarded UQ fellowship
04 March, 2011
Professor John Quackenbush has been offered an Australian Fellowship to join the University of Queensland's Institute for Molecular Bioscience.
International Year of Chemistry highlights importance of water
03 March, 2011
The United Nations has declared 2011 the International Year of Chemistry, which includes an international initiative that highlights the role chemistry plays in issues of water quality and purification.
Accurate Detection and Accurate Measurement acquired by Hach
02 March, 2011 | Supplied by: Hach Pacific Pty Ltd
Hach Company has acquired Accurate Detection and Accurate Measurement.
Regulation and harmonisation of genomic data
02 March, 2011
21 CFR 312.23, 21 CFR 314.50, and 21 CFR 314.81 codify the regulations and guidelines regarding genomic data and applications to the USFDA. This matrix of genomic data submissions requirements and voluntary guides are confusing and difficult to navigate.
Australian Synchrotron appoints new Director
01 March, 2011
The Australian Synchrotron has announced four new senior appointments, including Professor Keith Nugent as Director, and a reorganisation of senior responsibilities.
IPTA and AusBiotech champion the Intellectual Property Laws Amendments
01 March, 2011
IPTA and AusBiotech are urging the Senate Legal and Consitutional Committee to favour the Intellectual Property Laws Amendments instead of patentable subject matter amendments, as they are more comprehensive in terms of Australian patent law.
